📊 RDNT Key Takeaways
Is RadNet, Inc. (RDNT) a Good Investment?
RadNet demonstrates revenue growth of 11.5% YoY but is plagued by deteriorating profitability with net income declining 209% YoY and operating margins compressing to just 3%. The critical concern is an interest coverage ratio of 0.9x, indicating the company cannot cover debt obligations from operating income, creating unsustainable leverage given the $1.1B debt load and negative net margins.
RadNet shows solid fundamental growth with 11.5% revenue expansion and strong free cash flow generation supported by ample liquidity. However, thin operating profitability, negative GAAP earnings, and sub-1.0x interest coverage temper the outlook until margins improve and debt service coverage strengthens.
Why Buy RadNet, Inc. Stock? RDNT Key Strengths
- Strong free cash flow generation of $224.7M (11% FCF margin)
- Solid revenue growth of 11.5% YoY demonstrates market demand
- Healthy liquidity with current ratio of 1.76x and $767.2M cash balance
- Double-digit revenue growth (+11.5% YoY)
- Robust cash generation (OCF $299M, 11% FCF margin)
- Strong liquidity with $767M cash and 1.76x current ratio
RDNT Stock Risks: RadNet, Inc. Investment Risks
- Unprofitable operations with -0.9% net margin and -$18.7M net income
- Interest coverage ratio of 0.9x indicates inability to service debt from operations
- Severe earnings deterioration with -209% YoY net income decline and -725% EPS decline
- High leverage (1.00x D/E) unsustainable for unprofitable company facing margin compression
- Negative net income and slim 3.0% operating margin
- Weak interest coverage (0.9x) indicating debt cost pressure
- Cost growth outpacing revenue (net income down YoY)
Key Metrics to Watch
- Path to profitability and operating margin recovery
- Interest coverage ratio improvement above 1.5x threshold
- Debt reduction progress and leverage normalization
- Interest coverage
- Operating margin
RadNet, Inc. (RDNT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
RadNet, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
RDNT Profit Margin, ROE & Profitability Analysis
RDNT vs Healthcare Sector: How RadNet, Inc. Compares
How RadNet, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is RadNet, Inc. Stock Overvalued? RDNT Valuation Analysis 2026
Based on fundamental analysis, RadNet, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
RadNet, Inc. Balance Sheet: RDNT Debt, Cash & Liquidity
RDNT Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: RadNet, Inc.'s revenue has grown significantly by 55% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.05 reflects profitable operations.
RDNT Revenue Growth, EPS Growth & YoY Performance
RDNT Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $461.1M | -$2.6M | $-0.04 |
| Q2 2025 | $459.7M | -$3.0M | $-0.04 |
| Q1 2025 | $431.7M | -$2.8M | $-0.04 |
| Q3 2024 | $402.0M | -$2.6M | $-0.04 |
| Q2 2024 | $403.7M | -$3.0M | $-0.04 |
| Q1 2024 | $390.6M | -$2.8M | $-0.04 |
| Q3 2023 | $350.0M | $668.0K | $0.01 |
| Q2 2023 | $354.4M | $7.9M | $0.12 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
RadNet, Inc. Dividends, Buybacks & Capital Allocation
RDNT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for RadNet, Inc. (CIK: 0000790526)
📋 Recent SEC Filings
❓ Frequently Asked Questions about RDNT
What is the AI rating for RDNT?
RadNet, Inc. (RDNT) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 74% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are RDNT's key strengths?
Claude: Strong free cash flow generation of $224.7M (11% FCF margin). Solid revenue growth of 11.5% YoY demonstrates market demand. ChatGPT: Double-digit revenue growth (+11.5% YoY). Robust cash generation (OCF $299M, 11% FCF margin).
What are the risks of investing in RDNT?
Claude: Unprofitable operations with -0.9% net margin and -$18.7M net income. Interest coverage ratio of 0.9x indicates inability to service debt from operations. ChatGPT: Negative net income and slim 3.0% operating margin. Weak interest coverage (0.9x) indicating debt cost pressure.
What is RDNT's revenue and growth?
RadNet, Inc. reported revenue of $2.0B.
Does RDNT pay dividends?
RadNet, Inc. pays dividends, with $0.8M distributed to shareholders in the trailing twelve months.
Where can I find RDNT SEC filings?
Official SEC filings for RadNet, Inc. (CIK: 0000790526) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is RDNT's EPS?
RadNet, Inc. has a diluted EPS of $-0.25.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is RDNT a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, RadNet, Inc. has a SELL rating with 74% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is RDNT stock overvalued or undervalued?
Valuation metrics for RDNT: ROE of -1.7% (sector avg: 15%), net margin of -0.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy RDNT stock in 2026?
Our dual AI analysis gives RadNet, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is RDNT's free cash flow?
RadNet, Inc.'s operating cash flow is $298.8M, with capital expenditures of $74.2M. FCF margin is 11.0%.
How does RDNT compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -0.9% (avg: 12%), ROE -1.7% (avg: 15%), current ratio 1.76 (avg: 2).